AMY BROWNING: Open Payments
NPI 1457732117 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$546 in 13 payments from 9 companies in 2025. Trend: 2023 $883 · 2024 $371 · 2025 $546
Food & beverage: $546
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $149 |
| ABBVIE INC. | 2 | $148 |
| Legend Biotech USA Inc. | 2 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $40 |
| Genentech USA, Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Karyopharm Therapeutics Inc. | 1 | $19 |
| SERVIER PHARMACEUTICALS LLC | 1 | $18 |
Products named: EPKINLY, Monjuvi, CARVYKTI, ICLUSIG, JAKAFI, Columvi, VENCLEXTA, PREVYMIS.
Industry payments across FL — which companies pay providers there.
